An Evaluation of California's Experiment With HOPE

NCT ID: NCT01237691

Last Updated: 2018-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drugs of Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HOPE supervision

Parolee supervised under California's new HOPE parole model.

Group Type EXPERIMENTAL

HOPE supervision

Intervention Type BEHAVIORAL

HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.

Parole-as-usual

Parolees supervised under California parole-as-usual.

Group Type ACTIVE_COMPARATOR

Parole-as-usual

Intervention Type BEHAVIORAL

Parolees are supervised under standard parole supervision practice in California.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HOPE supervision

HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.

Intervention Type BEHAVIORAL

Parole-as-usual

Parolees are supervised under standard parole supervision practice in California.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HOPE COPE Routine parole

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Assigned to the Sacramento Metro IV Parole Unit.
* Released from a term of return-to-custody for a violation for, or involving, the use of drugs.
* Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

Exclusion Criteria

* History of convictions for crimes that require registration under Penal Code Section 290.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Irvine

OTHER

Sponsor Role collaborator

University of California, Los Angeles

OTHER

Sponsor Role collaborator

Pepperdine University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angela Hawken, PhD

Role: PRINCIPAL_INVESTIGATOR

Pepperdine University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sacramento Metro IV Parole Unit.

Sacramento, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SPPN1110F01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Buprenorphine for Prisoners
NCT00574067 COMPLETED PHASE3
Methadone Maintenance for Prisoners
NCT00378079 COMPLETED PHASE3
Galantamine and CBT4CBT Pilot to Prevent Relapse.
NCT03547622 COMPLETED EARLY_PHASE1
Buprenorphine Maintenance Protocol - 1
NCT00000205 COMPLETED PHASE3